Global Pet Tumor Screening Services Market Growth (Status and Outlook) 2026-2032

Product Code: 2007200

Industry: Service & Software

Published: May 31,2026

Pages: 118

Delivery Time: 2-3 business days

Global Pet Tumor Screening Services Market Growth (Status and Outlook) 2026-2032

Product Code: 2007200

Industry: Service & Software

Published: May 31,2026

Pages: 118

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Pet Tumor Screening Services market size is predicted to grow from US$ 621 million in 2025 to US$ 1029 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032.

Pet Tumor Screening Service refers to a cancer risk assessment and early screening service for companion animals such as dogs and cats. It typically uses blood, urine, cytology samples, or other biological specimens to detect tumor-related biomarkers, nucleosome signals, circulating cell-free DNA, genetic mutations, epigenetic features, or abnormal cellular morphology, thereby helping assess potential cancer risk in pets. The service is commonly used in annual wellness checkups for senior pets, screening of high-risk breeds, adjunctive diagnosis for suspicious clinical signs, and post-treatment recurrence monitoring. It does not fully replace imaging, histopathology, or clinical diagnosis, but serves as an important front-end tool for early cancer detection and pet health management. The price of Pet Tumor Screening Services varies significantly, with basic blood- or urine-based screening typically priced at around USD 100–300 per test, while higher-end liquid biopsy, genomic, or epigenomic testing usually costs around USD 500–1,000 per test.

The upstream supply chain of Pet Tumor Screening Service includes antibodies, enzymes, primers and probes, sequencing reagents, sample collection tubes, preservation solutions, diagnostic kits, testing instruments, automated analysis platforms, AI pathology algorithms, and bioinformatics systems. Core reagents and analytical models directly influence test sensitivity, specificity, and result interpretation. Midstream participants mainly include veterinary diagnostic laboratories, pet molecular diagnostics companies, liquid biopsy developers, digital pathology platforms, and large pet healthcare groups, which are responsible for assay development, sample processing, laboratory testing, report generation, and clinical interpretation. Downstream users include veterinary hospitals, clinics, veterinary oncology centers, pet wellness providers, breeding institutions, and premium pet health management customers, with services delivered through clinic-based sample submission, in-clinic testing, at-home sample collection, or pet wellness packages.

The Pet Tumor Screening Service market is at an early growth stage, driven by the increasing sophistication and preventive orientation of pet healthcare. Demand is mainly supported by pet aging, rising owner awareness of health management, the growing burden of cancer in companion animals, and the upgrading of premium veterinary wellness packages. Compared with traditional pathology and imaging diagnostics, these services emphasize early screening, non-invasive or minimally invasive sampling, repeatable monitoring, and convenient delivery, giving them strong commercialization potential in senior pets, high-risk breeds, and post-treatment follow-up scenarios. Future competition will focus on test accuracy, clinical validation, veterinary channel coverage, report interpretability, price acceptance, and integration with imaging, pathology, and treatment services. Companies with strong brand trust and laboratory network advantages are more likely to achieve scalable growth.

LPI (LP Information)' newest research report, the “Pet Tumor Screening Services Industry Forecast” looks at past sales and reviews total world Pet Tumor Screening Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Pet Tumor Screening Services sales for 2026 through 2032. With Pet Tumor Screening Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Tumor Screening Services industry.

This Insight Report provides a comprehensive analysis of the global Pet Tumor Screening Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pet Tumor Screening Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Tumor Screening Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Tumor Screening Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Tumor Screening Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet Tumor Screening Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Blood Biomarker-Based Tumor Screening Services
    Liquid Biopsy and Genomic Testing Services
    Urine-Based or Volatile Metabolite Screening Services
    AI Cytology and Digital Pathology Screening Services

Segmentation by Service Delivery Model:
    In-Clinic Point-of-Care Testing
    Central Reference Laboratory Testing
    At-Home Sample Collection and Mail-In Testing
    Integrated Veterinary Oncology Screening Services

Segmentation by Screening Purpose:
    Annual Wellness Cancer Screening
    Adjunctive Diagnosis for Suspected Cancer
    Recurrence and Disease Monitoring
    High-Risk Breed Screening

Segmentation by Application:
    Pet Annual Wellness Checkups
    Initial Tumor Screening in Veterinary Clinics
    Post-Surgery and Post-Treatment Monitoring
    Premium Pet Healthcare and Insurance-Linked Screening

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    IDEXX Laboratories
    Zoetis Diagnostics
    Antech Diagnostics
    VolitionRx
    VDI Laboratory
    Oncotect
    CanCan Diagnostics
    Oxford BioDynamics
    FUJIFILM VET Systems
    Veterinary Pathology Group
    NationWide Laboratories
    BioGuard Corporation
    PETcision Biotech
    Uni-Pharma

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Pet Tumor Screening Services Market Size (2021-2032)
        2.1.2 Pet Tumor Screening Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
        2.1.3 World Current & Future Analysis for Pet Tumor Screening Services by Country/Region (2021, 2025 & 2032)
    2.2 Pet Tumor Screening Services Segment by Type
        2.2.1 Blood Biomarker-Based Tumor Screening Services
        2.2.2 Liquid Biopsy and Genomic Testing Services
        2.2.3 Urine-Based or Volatile Metabolite Screening Services
        2.2.4 AI Cytology and Digital Pathology Screening Services
        2.2.5 Pet Tumor Screening Services Market Size by Type
            2.2.5.1 Pet Tumor Screening Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
            2.2.5.2 Global Pet Tumor Screening Services Market Size Market Share by Type (2021-2026)
    2.3 Pet Tumor Screening Services Segment by Service Delivery Model
        2.3.1 In-Clinic Point-of-Care Testing
        2.3.2 Central Reference Laboratory Testing
        2.3.3 At-Home Sample Collection and Mail-In Testing
        2.3.4 Integrated Veterinary Oncology Screening Services
        2.3.5 Pet Tumor Screening Services Market Size by Service Delivery Model
            2.3.5.1 Pet Tumor Screening Services Market Size CAGR by Service Delivery Model (2021 VS 2025 VS 2032)
            2.3.5.2 Global Pet Tumor Screening Services Market Size Market Share by Service Delivery Model (2021-2026)
    2.4 Pet Tumor Screening Services Segment by Screening Purpose
        2.4.1 Annual Wellness Cancer Screening
        2.4.2 Adjunctive Diagnosis for Suspected Cancer
        2.4.3 Recurrence and Disease Monitoring
        2.4.4 High-Risk Breed Screening
        2.4.5 Pet Tumor Screening Services Market Size by Screening Purpose
            2.4.5.1 Pet Tumor Screening Services Market Size CAGR by Screening Purpose (2021 VS 2025 VS 2032)
            2.4.5.2 Global Pet Tumor Screening Services Market Size Market Share by Screening Purpose (2021-2026)
    2.5 Pet Tumor Screening Services Segment by Application
        2.5.1 Pet Annual Wellness Checkups
        2.5.2 Initial Tumor Screening in Veterinary Clinics
        2.5.3 Post-Surgery and Post-Treatment Monitoring
        2.5.4 Premium Pet Healthcare and Insurance-Linked Screening
        2.5.5 Pet Tumor Screening Services Market Size by Application
            2.5.5.1 Pet Tumor Screening Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
            2.5.5.2 Global Pet Tumor Screening Services Market Size Market Share by Application (2021-2026)

3 Pet Tumor Screening Services Market Size by Player
    3.1 Pet Tumor Screening Services Market Size Market Share by Player
        3.1.1 Global Pet Tumor Screening Services Revenue by Player (2021-2026)
        3.1.2 Global Pet Tumor Screening Services Revenue Market Share by Player (2021-2026)
    3.2 Global Pet Tumor Screening Services Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Pet Tumor Screening Services by Region
    4.1 Pet Tumor Screening Services Market Size by Region (2021-2026)
    4.2 Global Pet Tumor Screening Services Annual Revenue by Country/Region (2021-2026)
    4.3 Americas Pet Tumor Screening Services Market Size Growth (2021-2026)
    4.4 APAC Pet Tumor Screening Services Market Size Growth (2021-2026)
    4.5 Europe Pet Tumor Screening Services Market Size Growth (2021-2026)
    4.6 Middle East & Africa Pet Tumor Screening Services Market Size Growth (2021-2026)

5 Americas
    5.1 Americas Pet Tumor Screening Services Market Size by Country (2021-2026)
    5.2 Americas Pet Tumor Screening Services Market Size by Type (2021-2026)
    5.3 Americas Pet Tumor Screening Services Market Size by Application (2021-2026)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Pet Tumor Screening Services Market Size by Region (2021-2026)
    6.2 APAC Pet Tumor Screening Services Market Size by Type (2021-2026)
    6.3 APAC Pet Tumor Screening Services Market Size by Application (2021-2026)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Pet Tumor Screening Services Market Size by Country (2021-2026)
    7.2 Europe Pet Tumor Screening Services Market Size by Type (2021-2026)
    7.3 Europe Pet Tumor Screening Services Market Size by Application (2021-2026)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Pet Tumor Screening Services by Region (2021-2026)
    8.2 Middle East & Africa Pet Tumor Screening Services Market Size by Type (2021-2026)
    8.3 Middle East & Africa Pet Tumor Screening Services Market Size by Application (2021-2026)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Pet Tumor Screening Services Market Forecast
    10.1 Global Pet Tumor Screening Services Forecast by Region (2027-2032)
        10.1.1 Global Pet Tumor Screening Services Forecast by Region (2027-2032)
        10.1.2 Americas Pet Tumor Screening Services Forecast
        10.1.3 APAC Pet Tumor Screening Services Forecast
        10.1.4 Europe Pet Tumor Screening Services Forecast
        10.1.5 Middle East & Africa Pet Tumor Screening Services Forecast
    10.2 Americas Pet Tumor Screening Services Forecast by Country (2027-2032)
        10.2.1 United States Market Pet Tumor Screening Services Forecast
        10.2.2 Canada Market Pet Tumor Screening Services Forecast
        10.2.3 Mexico Market Pet Tumor Screening Services Forecast
        10.2.4 Brazil Market Pet Tumor Screening Services Forecast
    10.3 APAC Pet Tumor Screening Services Forecast by Region (2027-2032)
        10.3.1 China Pet Tumor Screening Services Market Forecast
        10.3.2 Japan Market Pet Tumor Screening Services Forecast
        10.3.3 Korea Market Pet Tumor Screening Services Forecast
        10.3.4 Southeast Asia Market Pet Tumor Screening Services Forecast
        10.3.5 India Market Pet Tumor Screening Services Forecast
        10.3.6 Australia Market Pet Tumor Screening Services Forecast
    10.4 Europe Pet Tumor Screening Services Forecast by Country (2027-2032)
        10.4.1 Germany Market Pet Tumor Screening Services Forecast
        10.4.2 France Market Pet Tumor Screening Services Forecast
        10.4.3 UK Market Pet Tumor Screening Services Forecast
        10.4.4 Italy Market Pet Tumor Screening Services Forecast
        10.4.5 Russia Market Pet Tumor Screening Services Forecast
    10.5 Middle East & Africa Pet Tumor Screening Services Forecast by Region (2027-2032)
        10.5.1 Egypt Market Pet Tumor Screening Services Forecast
        10.5.2 South Africa Market Pet Tumor Screening Services Forecast
        10.5.3 Israel Market Pet Tumor Screening Services Forecast
        10.5.4 Turkey Market Pet Tumor Screening Services Forecast
    10.6 Global Pet Tumor Screening Services Forecast by Type (2027-2032)
    10.7 Global Pet Tumor Screening Services Forecast by Application (2027-2032)
        10.7.1 GCC Countries Market Pet Tumor Screening Services Forecast

11 Key Players Analysis
    11.1 IDEXX Laboratories
        11.1.1 IDEXX Laboratories Company Information
        11.1.2 IDEXX Laboratories Pet Tumor Screening Services Product Offered
        11.1.3 IDEXX Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.1.4 IDEXX Laboratories Main Business Overview
        11.1.5 IDEXX Laboratories Latest Developments
    11.2 Zoetis Diagnostics
        11.2.1 Zoetis Diagnostics Company Information
        11.2.2 Zoetis Diagnostics Pet Tumor Screening Services Product Offered
        11.2.3 Zoetis Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.2.4 Zoetis Diagnostics Main Business Overview
        11.2.5 Zoetis Diagnostics Latest Developments
    11.3 Antech Diagnostics
        11.3.1 Antech Diagnostics Company Information
        11.3.2 Antech Diagnostics Pet Tumor Screening Services Product Offered
        11.3.3 Antech Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.3.4 Antech Diagnostics Main Business Overview
        11.3.5 Antech Diagnostics Latest Developments
    11.4 VolitionRx
        11.4.1 VolitionRx Company Information
        11.4.2 VolitionRx Pet Tumor Screening Services Product Offered
        11.4.3 VolitionRx Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.4.4 VolitionRx Main Business Overview
        11.4.5 VolitionRx Latest Developments
    11.5 VDI Laboratory
        11.5.1 VDI Laboratory Company Information
        11.5.2 VDI Laboratory Pet Tumor Screening Services Product Offered
        11.5.3 VDI Laboratory Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.5.4 VDI Laboratory Main Business Overview
        11.5.5 VDI Laboratory Latest Developments
    11.6 Oncotect
        11.6.1 Oncotect Company Information
        11.6.2 Oncotect Pet Tumor Screening Services Product Offered
        11.6.3 Oncotect Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.6.4 Oncotect Main Business Overview
        11.6.5 Oncotect Latest Developments
    11.7 CanCan Diagnostics
        11.7.1 CanCan Diagnostics Company Information
        11.7.2 CanCan Diagnostics Pet Tumor Screening Services Product Offered
        11.7.3 CanCan Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.7.4 CanCan Diagnostics Main Business Overview
        11.7.5 CanCan Diagnostics Latest Developments
    11.8 Oxford BioDynamics
        11.8.1 Oxford BioDynamics Company Information
        11.8.2 Oxford BioDynamics Pet Tumor Screening Services Product Offered
        11.8.3 Oxford BioDynamics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.8.4 Oxford BioDynamics Main Business Overview
        11.8.5 Oxford BioDynamics Latest Developments
    11.9 FUJIFILM VET Systems
        11.9.1 FUJIFILM VET Systems Company Information
        11.9.2 FUJIFILM VET Systems Pet Tumor Screening Services Product Offered
        11.9.3 FUJIFILM VET Systems Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.9.4 FUJIFILM VET Systems Main Business Overview
        11.9.5 FUJIFILM VET Systems Latest Developments
    11.10 Veterinary Pathology Group
        11.10.1 Veterinary Pathology Group Company Information
        11.10.2 Veterinary Pathology Group Pet Tumor Screening Services Product Offered
        11.10.3 Veterinary Pathology Group Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.10.4 Veterinary Pathology Group Main Business Overview
        11.10.5 Veterinary Pathology Group Latest Developments
    11.11 NationWide Laboratories
        11.11.1 NationWide Laboratories Company Information
        11.11.2 NationWide Laboratories Pet Tumor Screening Services Product Offered
        11.11.3 NationWide Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.11.4 NationWide Laboratories Main Business Overview
        11.11.5 NationWide Laboratories Latest Developments
    11.12 BioGuard Corporation
        11.12.1 BioGuard Corporation Company Information
        11.12.2 BioGuard Corporation Pet Tumor Screening Services Product Offered
        11.12.3 BioGuard Corporation Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.12.4 BioGuard Corporation Main Business Overview
        11.12.5 BioGuard Corporation Latest Developments
    11.13 PETcision Biotech
        11.13.1 PETcision Biotech Company Information
        11.13.2 PETcision Biotech Pet Tumor Screening Services Product Offered
        11.13.3 PETcision Biotech Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.13.4 PETcision Biotech Main Business Overview
        11.13.5 PETcision Biotech Latest Developments
    11.14 Uni-Pharma
        11.14.1 Uni-Pharma Company Information
        11.14.2 Uni-Pharma Pet Tumor Screening Services Product Offered
        11.14.3 Uni-Pharma Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
        11.14.4 Uni-Pharma Main Business Overview
        11.14.5 Uni-Pharma Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Pet Tumor Screening Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
 Table 2. Pet Tumor Screening Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
 Table 3. Major Players of Blood Biomarker-Based Tumor Screening Services
 Table 4. Major Players of Liquid Biopsy and Genomic Testing Services
 Table 5. Major Players of Urine-Based or Volatile Metabolite Screening Services
 Table 6. Major Players of AI Cytology and Digital Pathology Screening Services
 Table 7. Pet Tumor Screening Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
 Table 8. Global Pet Tumor Screening Services Market Size by Type (2021-2026) & ($ millions)
 Table 9. Global Pet Tumor Screening Services Market Size Market Share by Type (2021-2026)
 Table 10. Major Players of In-Clinic Point-of-Care Testing
 Table 11. Major Players of Central Reference Laboratory Testing
 Table 12. Major Players of At-Home Sample Collection and Mail-In Testing
 Table 13. Major Players of Integrated Veterinary Oncology Screening Services
 Table 14. Pet Tumor Screening Services Market Size CAGR by Service Delivery Model (2021 VS 2025 VS 2032) & ($ millions)
 Table 15. Global Pet Tumor Screening Services Market Size by Service Delivery Model (2021-2026) & ($ millions)
 Table 16. Global Pet Tumor Screening Services Market Size Market Share by Service Delivery Model (2021-2026)
 Table 17. Major Players of Annual Wellness Cancer Screening
 Table 18. Major Players of Adjunctive Diagnosis for Suspected Cancer
 Table 19. Major Players of Recurrence and Disease Monitoring
 Table 20. Major Players of High-Risk Breed Screening
 Table 21. Pet Tumor Screening Services Market Size CAGR by Screening Purpose (2021 VS 2025 VS 2032) & ($ millions)
 Table 22. Global Pet Tumor Screening Services Market Size by Screening Purpose (2021-2026) & ($ millions)
 Table 23. Global Pet Tumor Screening Services Market Size Market Share by Screening Purpose (2021-2026)
 Table 24. Pet Tumor Screening Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
 Table 25. Global Pet Tumor Screening Services Market Size by Application (2021-2026) & ($ millions)
 Table 26. Global Pet Tumor Screening Services Market Size Market Share by Application (2021-2026)
 Table 27. Global Pet Tumor Screening Services Revenue by Player (2021-2026) & ($ millions)
 Table 28. Global Pet Tumor Screening Services Revenue Market Share by Player (2021-2026)
 Table 29. Pet Tumor Screening Services Key Players Head office and Products Offered
 Table 30. Pet Tumor Screening Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
 Table 31. New Products and Potential Entrants
 Table 32. Mergers & Acquisitions, Expansion
 Table 33. Global Pet Tumor Screening Services Market Size by Region (2021-2026) & ($ millions)
 Table 34. Global Pet Tumor Screening Services Market Size Market Share by Region (2021-2026)
 Table 35. Global Pet Tumor Screening Services Revenue by Country/Region (2021-2026) & ($ millions)
 Table 36. Global Pet Tumor Screening Services Revenue Market Share by Country/Region (2021-2026)
 Table 37. Americas Pet Tumor Screening Services Market Size by Country (2021-2026) & ($ millions)
 Table 38. Americas Pet Tumor Screening Services Market Size Market Share by Country (2021-2026)
 Table 39. Americas Pet Tumor Screening Services Market Size by Type (2021-2026) & ($ millions)
 Table 40. Americas Pet Tumor Screening Services Market Size Market Share by Type (2021-2026)
 Table 41. Americas Pet Tumor Screening Services Market Size by Application (2021-2026) & ($ millions)
 Table 42. Americas Pet Tumor Screening Services Market Size Market Share by Application (2021-2026)
 Table 43. APAC Pet Tumor Screening Services Market Size by Region (2021-2026) & ($ millions)
 Table 44. APAC Pet Tumor Screening Services Market Size Market Share by Region (2021-2026)
 Table 45. APAC Pet Tumor Screening Services Market Size by Type (2021-2026) & ($ millions)
 Table 46. APAC Pet Tumor Screening Services Market Size by Application (2021-2026) & ($ millions)
 Table 47. Europe Pet Tumor Screening Services Market Size by Country (2021-2026) & ($ millions)
 Table 48. Europe Pet Tumor Screening Services Market Size Market Share by Country (2021-2026)
 Table 49. Europe Pet Tumor Screening Services Market Size by Type (2021-2026) & ($ millions)
 Table 50. Europe Pet Tumor Screening Services Market Size by Application (2021-2026) & ($ millions)
 Table 51. Middle East & Africa Pet Tumor Screening Services Market Size by Region (2021-2026) & ($ millions)
 Table 52. Middle East & Africa Pet Tumor Screening Services Market Size by Type (2021-2026) & ($ millions)
 Table 53. Middle East & Africa Pet Tumor Screening Services Market Size by Application (2021-2026) & ($ millions)
 Table 54. Key Market Drivers & Growth Opportunities of Pet Tumor Screening Services
 Table 55. Key Market Challenges & Risks of Pet Tumor Screening Services
 Table 56. Key Industry Trends of Pet Tumor Screening Services
 Table 57. Global Pet Tumor Screening Services Market Size Forecast by Region (2027-2032) & ($ millions)
 Table 58. Global Pet Tumor Screening Services Market Size Market Share Forecast by Region (2027-2032)
 Table 59. Global Pet Tumor Screening Services Market Size Forecast by Type (2027-2032) & ($ millions)
 Table 60. Global Pet Tumor Screening Services Market Size Forecast by Application (2027-2032) & ($ millions)
 Table 61. IDEXX Laboratories Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 62. IDEXX Laboratories Pet Tumor Screening Services Product Offered
 Table 63. IDEXX Laboratories Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 64. IDEXX Laboratories Main Business
 Table 65. IDEXX Laboratories Latest Developments
 Table 66. Zoetis Diagnostics Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 67. Zoetis Diagnostics Pet Tumor Screening Services Product Offered
 Table 68. Zoetis Diagnostics Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 69. Zoetis Diagnostics Main Business
 Table 70. Zoetis Diagnostics Latest Developments
 Table 71. Antech Diagnostics Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 72. Antech Diagnostics Pet Tumor Screening Services Product Offered
 Table 73. Antech Diagnostics Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 74. Antech Diagnostics Main Business
 Table 75. Antech Diagnostics Latest Developments
 Table 76. VolitionRx Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 77. VolitionRx Pet Tumor Screening Services Product Offered
 Table 78. VolitionRx Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 79. VolitionRx Main Business
 Table 80. VolitionRx Latest Developments
 Table 81. VDI Laboratory Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 82. VDI Laboratory Pet Tumor Screening Services Product Offered
 Table 83. VDI Laboratory Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 84. VDI Laboratory Main Business
 Table 85. VDI Laboratory Latest Developments
 Table 86. Oncotect Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 87. Oncotect Pet Tumor Screening Services Product Offered
 Table 88. Oncotect Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 89. Oncotect Main Business
 Table 90. Oncotect Latest Developments
 Table 91. CanCan Diagnostics Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 92. CanCan Diagnostics Pet Tumor Screening Services Product Offered
 Table 93. CanCan Diagnostics Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 94. CanCan Diagnostics Main Business
 Table 95. CanCan Diagnostics Latest Developments
 Table 96. Oxford BioDynamics Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 97. Oxford BioDynamics Pet Tumor Screening Services Product Offered
 Table 98. Oxford BioDynamics Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 99. Oxford BioDynamics Main Business
 Table 100. Oxford BioDynamics Latest Developments
 Table 101. FUJIFILM VET Systems Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 102. FUJIFILM VET Systems Pet Tumor Screening Services Product Offered
 Table 103. FUJIFILM VET Systems Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 104. FUJIFILM VET Systems Main Business
 Table 105. FUJIFILM VET Systems Latest Developments
 Table 106. Veterinary Pathology Group Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 107. Veterinary Pathology Group Pet Tumor Screening Services Product Offered
 Table 108. Veterinary Pathology Group Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 109. Veterinary Pathology Group Main Business
 Table 110. Veterinary Pathology Group Latest Developments
 Table 111. NationWide Laboratories Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 112. NationWide Laboratories Pet Tumor Screening Services Product Offered
 Table 113. NationWide Laboratories Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 114. NationWide Laboratories Main Business
 Table 115. NationWide Laboratories Latest Developments
 Table 116. BioGuard Corporation Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 117. BioGuard Corporation Pet Tumor Screening Services Product Offered
 Table 118. BioGuard Corporation Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 119. BioGuard Corporation Main Business
 Table 120. BioGuard Corporation Latest Developments
 Table 121. PETcision Biotech Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 122. PETcision Biotech Pet Tumor Screening Services Product Offered
 Table 123. PETcision Biotech Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 124. PETcision Biotech Main Business
 Table 125. PETcision Biotech Latest Developments
 Table 126. Uni-Pharma Details, Company Type, Pet Tumor Screening Services Area Served and Its Competitors
 Table 127. Uni-Pharma Pet Tumor Screening Services Product Offered
 Table 128. Uni-Pharma Pet Tumor Screening Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 129. Uni-Pharma Main Business
 Table 130. Uni-Pharma Latest Developments


List of Figures
 Figure 1. Pet Tumor Screening Services Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Pet Tumor Screening Services Market Size Growth Rate (2021-2032) ($ millions)
 Figure 6. Pet Tumor Screening Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Figure 7. Pet Tumor Screening Services Sales Market Share by Country/Region (2025)
 Figure 8. Pet Tumor Screening Services Sales Market Share by Country/Region (2021, 2025 & 2032)
 Figure 9. Global Pet Tumor Screening Services Market Size Market Share by Type in 2025
 Figure 10. Global Pet Tumor Screening Services Market Size Market Share by Service Delivery Model in 2025
 Figure 11. Global Pet Tumor Screening Services Market Size Market Share by Screening Purpose in 2025
 Figure 12. Pet Tumor Screening Services in Pet Annual Wellness Checkups
 Figure 13. Global Pet Tumor Screening Services Market: Pet Annual Wellness Checkups (2021-2026) & ($ millions)
 Figure 14. Pet Tumor Screening Services in Initial Tumor Screening in Veterinary Clinics
 Figure 15. Global Pet Tumor Screening Services Market: Initial Tumor Screening in Veterinary Clinics (2021-2026) & ($ millions)
 Figure 16. Pet Tumor Screening Services in Post-Surgery and Post-Treatment Monitoring
 Figure 17. Global Pet Tumor Screening Services Market: Post-Surgery and Post-Treatment Monitoring (2021-2026) & ($ millions)
 Figure 18. Pet Tumor Screening Services in Premium Pet Healthcare and Insurance-Linked Screening
 Figure 19. Global Pet Tumor Screening Services Market: Premium Pet Healthcare and Insurance-Linked Screening (2021-2026) & ($ millions)
 Figure 20. Global Pet Tumor Screening Services Market Size Market Share by Application in 2025
 Figure 21. Global Pet Tumor Screening Services Revenue Market Share by Player in 2025
 Figure 22. Global Pet Tumor Screening Services Market Size Market Share by Region (2021-2026)
 Figure 23. Americas Pet Tumor Screening Services Market Size 2021-2026 ($ millions)
 Figure 24. APAC Pet Tumor Screening Services Market Size 2021-2026 ($ millions)
 Figure 25. Europe Pet Tumor Screening Services Market Size 2021-2026 ($ millions)
 Figure 26. Middle East & Africa Pet Tumor Screening Services Market Size 2021-2026 ($ millions)
 Figure 27. Americas Pet Tumor Screening Services Value Market Share by Country in 2025
 Figure 28. United States Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 29. Canada Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 30. Mexico Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 31. Brazil Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 32. APAC Pet Tumor Screening Services Market Size Market Share by Region in 2025
 Figure 33. APAC Pet Tumor Screening Services Market Size Market Share by Type (2021-2026)
 Figure 34. APAC Pet Tumor Screening Services Market Size Market Share by Application (2021-2026)
 Figure 35. China Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 36. Japan Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 37. South Korea Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 38. Southeast Asia Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 39. India Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 40. Australia Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 41. Europe Pet Tumor Screening Services Market Size Market Share by Country in 2025
 Figure 42. Europe Pet Tumor Screening Services Market Size Market Share by Type (2021-2026)
 Figure 43. Europe Pet Tumor Screening Services Market Size Market Share by Application (2021-2026)
 Figure 44. Germany Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 45. France Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 46. UK Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 47. Italy Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 48. Russia Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 49. Middle East & Africa Pet Tumor Screening Services Market Size Market Share by Region (2021-2026)
 Figure 50. Middle East & Africa Pet Tumor Screening Services Market Size Market Share by Type (2021-2026)
 Figure 51. Middle East & Africa Pet Tumor Screening Services Market Size Market Share by Application (2021-2026)
 Figure 52. Egypt Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 53. South Africa Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 54. Israel Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 55. Turkey Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 56. GCC Countries Pet Tumor Screening Services Market Size Growth 2021-2026 ($ millions)
 Figure 57. Americas Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 58. APAC Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 59. Europe Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 60. Middle East & Africa Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 61. United States Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 62. Canada Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 63. Mexico Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 64. Brazil Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 65. China Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 66. Japan Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 67. Korea Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 68. Southeast Asia Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 69. India Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 70. Australia Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 71. Germany Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 72. France Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 73. UK Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 74. Italy Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 75. Russia Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 76. Egypt Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 77. South Africa Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 78. Israel Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 79. Turkey Pet Tumor Screening Services Market Size 2027-2032 ($ millions)
 Figure 80. Global Pet Tumor Screening Services Market Size Market Share Forecast by Type (2027-2032)
 Figure 81. Global Pet Tumor Screening Services Market Size Market Share Forecast by Application (2027-2032)
 Figure 82. GCC Countries Pet Tumor Screening Services Market Size 2027-2032 ($ millions)

Companies Mentioned

IDEXX Laboratories

Zoetis Diagnostics

Antech Diagnostics

VolitionRx

VDI Laboratory

Oncotect

CanCan Diagnostics

Oxford BioDynamics

FUJIFILM VET Systems

Veterinary Pathology Group

NationWide Laboratories

BioGuard Corporation

PETcision Biotech

Uni-Pharma

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff